Mini Review: Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Shamabadi Ahmad; Mahmoudi Hamidreza; DANESHPAZHOOH MARYAM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Iranian Medical Council Year:2021 | Volume:4 | Issue:2 Page(s): 60-63

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Mini Review: Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence

Author(s)

Shamabadi Ahmad | Mahmoudi Hamidreza | DANESHPAZHOOH MARYAM | Issue Writer Certificate

Keywords

Coronavirus

COVID-19

Neoplasms

Pandemics

Rituximab

Abstract

Rituximab (RTX), as a B cell-depleting agent, is indicated in treating several malignancies and autoimmune diseases. The management of patients currently receiving RTX and patients starting the medication raised concerns in the pandemic era. Theoretically, suppressing the immune response at the beginning of Coronavirus disease 2019 (COVID-19) enhances viral replication, but it prevents acute respiratory distress syndrome as the disease progresses. This review aims to investigate the results of RTX administration in patients during the pandemic era. There is insufficient evidence to definitively conclude on the safety of RTX during the pandemic. For this purpose, high-quality controlled cohort studies, as well as registry-based studies, would be helpful.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

Shamabadi, Ahmad, Mahmoudi, Hamidreza, & DANESHPAZHOOH, MARYAM. (2021). Mini Review: Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence. JOURNAL OF IRANIAN MEDICAL COUNCIL, 4(2), 60-63. SID. https://sid.ir/paper/1056514/en

Vancouver: Copy

Shamabadi Ahmad, Mahmoudi Hamidreza, DANESHPAZHOOH MARYAM. Mini Review: Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence. JOURNAL OF IRANIAN MEDICAL COUNCIL[Internet]. 2021;4(2):60-63. Available from: https://sid.ir/paper/1056514/en

IEEE: Copy

Ahmad Shamabadi, Hamidreza Mahmoudi, and MARYAM DANESHPAZHOOH, “Mini Review: Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence,” JOURNAL OF IRANIAN MEDICAL COUNCIL, vol. 4, no. 2, pp. 60–63, 2021, [Online]. Available: https://sid.ir/paper/1056514/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops